MD Anderson Cancer Center scientists discovered a new biomarker that can predict “survival outcomes for patients with advanced KRAS G12C-mutated non-small cell ...
Company’s AD-Detect portfolio offers AB 42/40 and other plasma biomarker testing, alongside traditional cerebrospinal fluid and genetic tests, to provide robust offering in brain...
The pathological foundation of numerous acute and chronic neurological disorders, leading to enduring disability, lies in neuroaxonal damage and loss. The capability to easily...